Micropace Pty Ltd

Micropace Pty Ltd, with the slogan "Simplifying Arrhythmia Diagnosis and Management by Manufacturing the Worlds Best Cardiac Stimulator," is a prominent player in the Health Care and Manufacturing industries. Established in 1995 and headquartered in Australia, the company has gained recognition for its significant contributions to cardiac electrophysiology. Micropace's flagship product family, EPS320, has set the global standard for cardiac stimulation and has been exported to over 50 countries, including the USA, most European Union countries, Asia Pacific, India, Japan, and China. The company has achieved over 800 installations in the US and 1500 worldwide, solidifying its position as a leader in the field. Driven by a mission to provide arrhythmia-free lives, Micropace focuses on delivering user-friendly and reliable products tailored to the needs of electrophysiologists. The company's success can be attributed to its intimate knowledge of clinical cardiac electrophysiology, collaborative partnerships with clinicians, and an agile development team that supports clinical research and responds to customer feedback. The recent CNY35.00M Series A investment received by Micropace in November 2021 from Qiming Venture Partners signifies investor confidence in the company's innovative technologies and global market presence. Micropace's global operations, with offices in California, Sydney, Australia, and the EU, underscore its commitment to expanding its reach and impact in the healthcare industry. For more information, visit http:\/\/micropaceep.com.